LONDON (Thomson Financial) - AIM-listed Vastox PLC said the European Patent Office has granted the key patent for its zebrafish disease modelling and chemical genomics technology, significantly increasing the value of its platform.
LONDON (Thomson Financial) - AIM-listed Vastox PLC said the European Patent Office has granted the key patent for its zebrafish disease modelling and chemical genomics technology, significantly increasing the value of its platform.
